PPT-Evaluating and Enhancing Adherence to Medications

Bernard Vrijens PhD Chief Science Officer MWV Healthcare Associate Professor of Biostatistics University of Liège Belgium Adherence is key to therapeutic success 2 Effective Disease Management. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Lessons from a 3-month Placebo Gel Trial at 3 US sites. Alex Carballo-Diéguez, Ph.D. .. Columbia University, NYC, US. Background. In the USA, young men who have sex with men (YMSM), especially those who are ethnic minorities, have high prevalence and incidence of HIV. B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Bukusi. . Kenya Medical Research Institute. University of Washington. University of California, San Franscisco . . Adherence crucial for success of any clinical drug trial and/or treatment. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Adherence is all about being conscientious in following medical advice. . This . section looks specifically at following recommendations for taking . Oral . PrEP. in MSM. Division of Global HIV and TB, CDC, New Delhi, India. Timothy H. . Holtz . (CDC/DHAP / Thailand MOPH – US CDC Collaboration). and HPTN . 067/ADAPT Study . Team. MOSY08, IAS. , . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. scenario in Nepal. Presentation By. :. Ms. Niru Khatiwada. BSc Nursing (BPKIHS), MN (IOM, TU). Lecturer, Nepal Medical College . (Affiliated to Kathmandu University). Kathmandu, Nepal. 1. OVERVIEW. OVERVIEW. Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. The Oberoi, Dubai, UAE. Dr Brendan Mitchell. Volume 46, Issue 2, pages 185–192, February 2016. http://www.mybabygifts.com.au/images/hospitals/the-northern-hospital-epping.jpg. http://www.hassell.com.au/en/cms-projects/detail/gold-coast-university-hospital-396. Team Members. Michael Ingram Jr, Heather Makwinski, Joshua Michalik, Samantha Taylor Talarico. 0. 2. 03. 01. BACKGROUND: The Business Case. Health Insurance. Companies. Medication non-adherence can have negative implications for the patient, the doctor/hospital, and insurance company.. With GLP-1 RAs. This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form.. . These data should be considered preliminary until published in a . 1 City in Addis Ababa A Proposal on the CHBC Project Lisan Atnafe: CHBC Project Officer Anley Haile : MNCH project advisor February 2013 2 Acronyms AIDS Acquired Immunodeficiency Syndrome AMREF Afr EPF Position Paper March 2015 2 Adherence and Concordance EPF position paper , March 2015 Contents 1 Introduction ................................ ................................ ....................